Abstract
Atherosclerosis is a multifactorial and multipart progressive disease manifested by the focal development within the arterial wall of lesions – the atherosclerotic plaques – in response to various deleterious insults that affect the vessel wall’s cells. Among the risk factors, as identified by classical epidemiology, there are dyslipidemia, vasoconstrictor hormones incriminated in hypertension, products of glycoxidation associated with hyperglycemia, pro-inflammatory cytokines and smoking, out of which the first is a prerequisite for the initiation and progression of about half of arterial lesions. In other instances, an inflammatory reaction induced by putative antigens that stimulate T lymphocytes, certain heat shock proteins, components of plasma lipoproteins, and potentially, microbial structures induce atherosclerotic plaque in the absence of systemic hypercholesterolemia [1, 2]. Thus, the process is more complex than previously thought. The conventional view that stressed the role of dyslipidemia in the generation of atherosclerosis was rounded by extensive evidence that inflammation is a key contributor to all stages of this disease, from the initial lesion to the ruptured plaque [2]. In all cases, the atheroma formation entails a progressive process in which the gradual implication of various cells and their secretory products define a sequence of events that leads from the fatty streak to fibro-lipid plaque, and ultimately to plaque rupture and atherothrombosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Millonig G, Malcom GT, Wick G (2002) Early inflammatory-immunological lesions in juvenile atherosclerosis from the pathobiological determinants of atherosclerosis in youth (PDAY)-study. Atherosclerosis 160:441–448
Libby P, Ridker PM, Göran K (2009) Hansson, inflammation in atherosclerosis, from pathophysiology to practice. J Am Coll Cardiol 54:2129–2138
Nielsen LB, Nordestgaard BG, Stender S, Kjeldsen K (1992) Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits. Arterioscler Thromb 12:1402–1409
Nordestgaard BG, Hjelms E, Stender S, Kjeldsen K (1990) Different efflux pathways for high and low density lipoproteins from porcine aortic intima. Arterioscler Thromb Vasc Biol 10:477–485
Schwenke DC, StClair RW (1993) Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol aggravated aortic atherosclerosis. Arterioscler Thromb 13:1368–1381
Vasile E, Antohe F, Simionescu M, Simionescu N (1989) Transport pathways of beta-VLDL by aortic endothelium of normal and hypercholesterolemic rabbits. Atherosclerosis 75:195–210
Nordestgaard BG, Hjelms E, Stender S, Kjeldsen K (1990) Different efflux pathways for high and low density lipoproteins from porcine aortic intima. Arteriosclerosis 10:477–485
Faggiotto A, Ross R, Harker L (1984) Studies of hypercholesterolemia in the nonhuman primate I. Changes that lead to fatty streak formation. Arterioscler Thromb Vasc Biol 4:323–340
Kruth HS (1983) Filipin-positive, oil red 0-negative particles in atherosclerotic lesions induced by cholesterol feeding. Lab Invest 50:87–93
Nistor A, Bulla A, Filip DA, Radu A (1987) The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68:159–173
Simionescu N, Vasile E, Lupu F, Popescu G, Simionescu M (1986) Prelesional events in atherogenesis: accumulation of extracellular cholesterol rich liposomes in the arterial intima and cardiac valves of hyperlipidemic rabbits. Am J Pathol 123:85–101
Kruth HS (1984) Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin positive, Oil-Red-0-negative particles. Am J Pathol 114:201–208
Tirziu D, Dobrian A, Tasca C, Simionescu M, Simionescu N (1995) Intimal thickenings of human aortas contain modified reassembled lipoproteins. Atherosclerosis 112:101–114
Sima A, Stancu C, Simionescu M (2009) Vascular endothelium in atherosclerosis. Cell Tissue Res 335:191–203
Tabas I, Williams KJ, Borén J (2007) Macrophages, apoptotic cells and cholesterol – strategies for survival. Circulation 116:1832–1844
Steinberg D (2009) The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50:S376–S381
Ishigakia Y, Okaa Y, Katagiri H (2009) Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 20:363–369
Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19–C31
Filip DA, Nistor A, Bulla A, Radu A, Simionescu M (1987) Cellular events in the development of the valvular atherosclerotic lesions induced by experimental atherosclerosis. Atherosclerosis 67:199–214
Sima A, Bulla A, Simionescu N (1990) Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J Submicrosc Cytol Pathol 22:1–6
Simionescu M (2007) Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266–274
Mompeo B, Popov D, Sima A, Constantinescu E, Simionescu M (1998) Diabetes induced structural changes of venous and arterial endothelium and smooth muscle cells. J Submicrosc Cytol Pathol 30:475–484
Sima A, Stancu C, Constantinescu E (2004) The hyperlipidemic hamster, a model to study atheroma formation and anti-atherosclerotic drugs effects. In: Simionescu M, Sima A, Popov D (eds) Cellular dysfunction in atherosclerosis and diabetes – reports from bench to bedside. Academy Publishing House, Bucharest, pp 309–322
Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA (1998) A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101:353–363
Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102:2185–2189
Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19(1):71–82
Weber C, Zernecke A, Libby P (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8:802–815
Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77–86
Davi G, Patrono C (2007) Platelet activation and atherothrombosis. New Engl J Med 357:2482–2494
Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
Packard RR, Lichtman AH, Libby P (2009) Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 31(1):5–22
Bobryshev YV (2005) Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 26:1700–1704
Weis M, Schlichting CL, Engleman EG, Cooke JP (2002) Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22:1817–1823
Galkina E, Ley K (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27:165–197
Packard RR, Maganto-Garcia E, Gotsman I, Tabas I, Libby P, Lichtman AH (2008) CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ Res 103:965–973
Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112:1461–1471
Soehnlein O, Weber C, Lindbom L (2009) Neutrophil granule proteins tune monocytic cell function. Trends Immunol 30:538–546
Soehnlein O, Lindbom L, Weber C (2009) Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 114:4613–4623
Zernecke A, Bot I, Djalali-Talab Y et al (2008) Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102:209–217
Luxa CA, Koschinskib A, Derscha K, Husmanna M, Bhakdia S (2009) Hypersusceptibility of neutrophil granulocytes towards lethal action of free fatty acids contained in enzyme-modified atherogenic low density lipoprotein. Atherosclerosis 207:116–122
Drechsler M, Megens RTA, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122:1837–1845
Baetta R, Corsini A (2010) Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 210:1–13
Lappalainen J, Lindstedt KA, Oksjoki R, Kovanen PT (2011) OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis 214(2):357–363
Kovanen PT (2009) Mast cells in atherogenesis: actions and reactions. Curr Atheroscler Rep 11:214–219
Tiwari RL, Singh V, Barthwal MK (2008) Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 28:483–544
Velican C, Velican D (1985) Study of coronary intimal thickening. Atherosclerosis 56:331–344
Stary HC (2000) Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20:1177–1178
Tabas I, Tall A, Accili D (2010) The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res 106:58–67
Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262–1275
Rudd JFH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M et al (2010) Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography. Ready for prime time? J Am Coll Cardiol 55:2527–2535
Kolodgie FD, Nakazawa G, Sangiorgi G, Ladich E, Burke AP, Virmani R (2007) Pathology of atherosclerosis and stenting. Neuroimaging Clin N Am 17(3):285–310
Watanabe M, Sangawa A, Sasaki Y, Yamashita M, Tanaka-Shintani M, Shintaku M, Ishikawa Y (2007) Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J Atheroscler Thromb 14:325–331
Langheinrich AC, Kampschulte M, Buch T, Bohle RM (2007) Vasa vasorum and atherosclerosis. Quid novi? Thromb Haemost 97:873–879
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag/Wien
About this chapter
Cite this chapter
Simionescu, M., Sima, A.V. (2012). Morphology of Atherosclerotic Lesions. In: Wick, G., Grundtman, C. (eds) Inflammation and Atherosclerosis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0338-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0338-8_2
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0337-1
Online ISBN: 978-3-7091-0338-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)